ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00769574
Recruitment Status : Completed
First Posted : October 9, 2008
Last Update Posted : August 29, 2014
Sponsor:
Information provided by (Responsible Party):
Assistance Publique Hopitaux De Marseille

Brief Summary:
To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS).

Condition or disease Intervention/treatment Phase
Coronary Syndrome Other: Biological analysis of biomarkers Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 143 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.
Study Start Date : June 2008
Actual Primary Completion Date : August 2011
Actual Study Completion Date : August 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Chest Pain
U.S. FDA Resources

Arm Intervention/treatment
Experimental: 1
Patients with coronary syndrome
Other: Biological analysis of biomarkers
Biological analysis of biomarkers
2
Subjects without coronary syndrome
Other: Biological analysis of biomarkers
Biological analysis of biomarkers



Primary Outcome Measures :
  1. To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS). [ Time Frame: 24 months ]

Secondary Outcome Measures :
  1. Compare the characteristics of biological markers to those of usual or innovative markers [ Time Frame: 24 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • subjects over 18 years,
  • subject about having a chest pain of coronary syndrome,
  • subject about not having received heparin or LMWH

Exclusion Criteria:

  • subject minor
  • subject without informed consent,
  • subject after receiving an anticoagulant treatment,
  • transplanted heart, kidney or liver

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00769574


Locations
France
Hôpital de la Timone- Service cardiologie A
Marseille, France, 13385
Sponsors and Collaborators
Assistance Publique Hopitaux De Marseille
Investigators
Principal Investigator: Jean-Louis BONNET, MD Assistance Publique des Hôpitaux de Marseille

Responsible Party: Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier: NCT00769574     History of Changes
Other Study ID Numbers: 2008-A00192-53
First Posted: October 9, 2008    Key Record Dates
Last Update Posted: August 29, 2014
Last Verified: August 2014

Additional relevant MeSH terms:
Syndrome
Acute Coronary Syndrome
Chest Pain
Disease
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms